Thyroid eye disease is a rare disease where muscles and fatty tissues behind the eyes become inflamed and cause the eyes to push forward and bulge outward. It can cause eye pain, double vision, light sensitivity or difficulty closing the eye.
The disease affects more women than men and can be incapacitating, preventing people from driving or working.
Tepezza is the first drug to be approved by the FDA to treat thyroid eye disease.
Read the full article here.
More articles on pharmacy:
Walgreens, CVS demands led Ohio Medicaid to drop 272 pharmacies, state says
How Civica Rx became a force in the generic drug industry: A timeline
10 most expensive drugs for Medicare Part D
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
